(PLRX) Pliant Therapeutics - Performance -89.1% in 12m
Compare PLRX with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-77.85%
#124 in Group
Rel. Strength
1.75%
#7818 in Universe
Total Return 12m
-89.11%
#186 in Group
Total Return 5y
-93.15%
#122 in Group
P/E -
(?) Percentile in Group
P/E Forward -
(?) Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -72.03%
38th Percentile in Group
12m Total Return: PLRX (-89.1%) vs XBI (-12.3%)
5y Drawdown (Underwater) Chart
Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| UTHR NASDAQ United Therapeutics |
10.1% | 18% | 166% | 12.1 | 11 | 1.43 | 74.6% | 16.1% |
| HLN NYSE Haleon |
14.3% | 31.2% | 47% | 24.4 | 20.2 | 1.79 | 69.1% | 13.6% |
| AMGN NASDAQ Amgen |
-2.93% | -8.78% | 30.7% | 25.5 | 13.5 | 0.95 | 0.60% | 41% |
| LONN SW Lonza |
9.55% | 9.34% | 30.4% | 67.1 | 35.1 | 1.28 | 2.20% | -12.5% |
| BIM PA Biomerieux |
0.78% | 17.8% | -2.14% | 32.5 | 25.2 | 1.52 | -38.5% | -25.1% |
| KMDA NASDAQ Kamada |
21.4% | 25.3% | -4.13% | 26.6 | 23.9 | 0.96 | 32.5% | 3.93% |
| NBIX NASDAQ Neurocrine Biosciences |
34.3% | -15.5% | 3.48% | 32.3 | 21.6 | 0.27 | 68.0% | 31.9% |
| ERF PA Eurofins Scientific SE |
20.4% | -0.39% | 7.63% | 26.6 | 13.6 | 0.56 | -66.6% | -17.1% |
Performance Comparison: PLRX vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for PLRX
| Total Return (including Dividends) | PLRX | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 19.18% | 11.81% | 13.81% |
| 3 Months | -52.44% | -13.61% | -6.30% |
| 12 Months | -89.11% | -12.29% | 10.65% |
| 5 Years | -93.15% | -24.89% | 107.77% |
| Trend Score (consistency of price movement) | PLRX | XBI | S&P 500 |
| 1 Month | 51.5% | 72.9% | 83% |
| 3 Months | -59.5% | -83% | -75.3% |
| 12 Months | -53.6% | -51.6% | 50.1% |
| 5 Years | -62.9% | -53.9% | 84.1% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
| 1 Month | #44 | 6.60% | 4.72% |
| 3 Month | #199 | -45.0% | -49.3% |
| 12 Month | #186 | -87.6% | -90.2% |
| 5 Years | #123 | -90.9% | -96.5% |
FAQs
Does PLRX Pliant Therapeutics outperforms the market?
No,
over the last 12 months PLRX made -89.11%, while its related Sector, the SPDR S&P Biotech (XBI) made -12.29%.
Over the last 3 months PLRX made -52.44%, while XBI made -13.61%.
Over the last 3 months PLRX made -52.44%, while XBI made -13.61%.
Performance Comparison PLRX vs Indeces and Sectors
PLRX vs. Indices PLRX is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -11.1% | 5.37% | -85.3% | -99.8% |
| US NASDAQ 100 | QQQ | -11.3% | 1.82% | -85.5% | -101% |
| US Dow Jones Industrial 30 | DIA | -11.5% | 9.19% | -85.0% | -96.8% |
| German DAX 40 | DAX | -11.0% | 4.22% | -112% | -115% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -13.2% | 7.35% | -86.1% | -96.5% |
| Hongkong Hang Seng | HSI | -14.2% | -0.75% | -93.7% | -103% |
| India NIFTY 50 | INDA | -6.14% | 14.3% | -85.8% | -88.9% |
| Brasil Bovespa | EWZ | -12.1% | 1.94% | -94.0% | -80.8% |
PLRX vs. Sectors PLRX is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -11.7% | 5.77% | -92.4% | -111% |
| Consumer Discretionary | XLY | -11.4% | 4.95% | -84.4% | -103% |
| Consumer Staples | XLP | -10.2% | 12.6% | -92.3% | -98.2% |
| Energy | XLE | -10.9% | 12.4% | -78.7% | -79.7% |
| Financial | XLF | -12.2% | 5.66% | -92.4% | -112% |
| Health Care | XLV | -8.05% | 18.3% | -80.3% | -85.1% |
| Industrial | XLI | -12.8% | 2.36% | -86.8% | -100% |
| Materials | XLB | -10.9% | 5.62% | -80.4% | -83.9% |
| Real Estate | XLRE | -9.74% | 7.64% | -86.1% | -105% |
| Technology | XLK | -12.1% | -2.04% | -82.5% | -96.2% |
| Utilities | XLU | -11.1% | 9.59% | -93.0% | -107% |
| Aerospace & Defense | XAR | -13.0% | -1.98% | -96.8% | -116% |
| Biotech | XBI | -4.47% | 7.37% | -65.2% | -76.8% |
| Homebuilder | XHB | -11.5% | 7.70% | -72.1% | -81.6% |
| Retail | XRT | -13.0% | 4.53% | -81.1% | -87.6% |